Trial Profile
Phase II study of TC 5619 in patients with Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 May 2011
Price :
$35
*
At a glance
- Drugs Bradanicline (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 03 May 2011 New trial record